15-72474873-TGGCGGCGGCGGCGGC-TGGCGGCGGCGGCGGCGGCGGC
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005744.5(ARIH1):c.252_257dupCGGCGG(p.Gly85_Gly86dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000565 in 1,413,090 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 0 hom. )
Consequence
ARIH1
NM_005744.5 disruptive_inframe_insertion
NM_005744.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.74
Genes affected
ARIH1 (HGNC:689): (ariadne RBR E3 ubiquitin protein ligase 1) Enables enzyme binding activity; ubiquitin-protein transferase activity; and zinc ion binding activity. Involved in protein ubiquitination. Located in Lewy body; cytoplasm; and nuclear body. Colocalizes with cullin-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 202 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARIH1 | NM_005744.5 | c.252_257dupCGGCGG | p.Gly85_Gly86dup | disruptive_inframe_insertion | 1/14 | ENST00000379887.9 | NP_005735.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARIH1 | ENST00000379887.9 | c.252_257dupCGGCGG | p.Gly85_Gly86dup | disruptive_inframe_insertion | 1/14 | 1 | NM_005744.5 | ENSP00000369217.4 | ||
ARIH1 | ENST00000564062.1 | c.246_251dupCGGCGG | p.Gly83_Gly84dup | disruptive_inframe_insertion | 1/4 | 3 | ENSP00000454774.1 | |||
TMEM202-AS1 | ENST00000565181.1 | n.290_295dupGCCGCC | non_coding_transcript_exon_variant | 1/1 | 6 | |||||
ARIH1 | ENST00000570085.5 | n.252_257dupCGGCGG | non_coding_transcript_exon_variant | 1/5 | 3 | ENSP00000456746.1 |
Frequencies
GnomAD3 genomes AF: 0.00133 AC: 199AN: 149694Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
199
AN:
149694
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000341 AC: 21AN: 61656Hom.: 0 AF XY: 0.000232 AC XY: 8AN XY: 34494
GnomAD3 exomes
AF:
AC:
21
AN:
61656
Hom.:
AF XY:
AC XY:
8
AN XY:
34494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000473 AC: 597AN: 1263290Hom.: 0 Cov.: 30 AF XY: 0.000475 AC XY: 294AN XY: 619586
GnomAD4 exome
AF:
AC:
597
AN:
1263290
Hom.:
Cov.:
30
AF XY:
AC XY:
294
AN XY:
619586
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00135 AC: 202AN: 149800Hom.: 0 Cov.: 32 AF XY: 0.00134 AC XY: 98AN XY: 73148
GnomAD4 genome
AF:
AC:
202
AN:
149800
Hom.:
Cov.:
32
AF XY:
AC XY:
98
AN XY:
73148
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This variant, c.252_257dup, results in the insertion of 2 amino acid(s) of the ARIH1 protein (p.Gly89_Gly90dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ARIH1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ARIH1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 02, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at